Inductive Camrelizumab and Apatinib for Patients With Locally Advanced and Resectable Oral Squamous Cell Carcinoma

Name: Inductive Camrelizumab and Apatinib for Patients With Locally Advanced and Resectable Oral Squamous Cell Carcinoma
License: Public Domain

Shanghai Jiao Tong University School of Medicine

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

oral cancer, vegfr2 inhibitor, programmed cell death 1 inhibitor, inductive therapy

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 252976
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.